Inner ear hair cells and supporting cells arise from common precursors and, in mammals, do not show phenotypic conversion. Here, we studied the role of the homeodomain transcription factor Prox1 in the inner ear sensory epithelia. Adenoviral-mediated Prox1 transduction into hair cells in explant cultures led to strong repression of Atoh1 and Gfi1, two transcription factors critical for hair cell differentiation and survival. Luciferase assays showed that Prox1 can repress transcriptional activity of Gfi1 independently of Atoh1. Prox1 transduction into cochlear outer hair cells resulted in degeneration of these cells, consistent with the known phenotype of Gfi1-deficient mice. These results together with the widespread expression of endogenous Prox1 within the population of inner ear supporting cells point to the role for Prox1 in antagonizing the hair cell phenotype in these non-sensory cells. Further, in vivo analyses of hair cells from Gfi1-deficient mice suggest that the cyclin-dependent kinase inhibitor p57 Kip2 mediates the differentiation-and survival-promoting functions of Gfi1. These data reveal novel gene interactions and show that these interactions regulate cellular differentiation within the inner ear sensory epithelia. The data point to the tight regulation of phenotypic characteristics of hair cells and supporting cells.
Introduction
Hair cells (HCs) and supporting cells of the inner ear arise from common progenitors (Fekete et al., 1998 ) that during embryogenesis exit the cell cycle and initiate cell type-specific differentiation, leading to the formation of the mosaic-like cytoarchitecture typical to the cochlear (organ of Corti) and vestibular sensory epithelia. Because of common origin, not only activators, but also repressors of the opposite phenotype are likely to be involved. The Notch signaling-based "lateral inhibition" is a key mechanism in cell fate specification in the sensory patches of the early-developing inner ear (Lewis, 1998) . As a result of signaling between Notch receptors and their ligands, and the induction of the basic helix-loop-helix (bHLH) transcription factor Atoh1, a subset of precursor cells start to differentiate as HCs, the primary cell type. Induction of Atoh1 is followed by upregulation of factors such as Gfi1 (for "growth factor independence 1") and myosin VIIa, which mark the onset of HC histogenesis (reviewed by Kelley, 2006) . Members of Hes (for "hairy and enhancer of split") and Id (for "inhibitor of differentiation and/or DNA binding") families have been suggested to promote supporting cell development by antagonizing Atoh1 activity Jones et al., 2006) . Signaling through fibroblast growth factor receptor 3 (Fgfr3) is crucial for the differentiation of specific supporting cell types in the organ of Corti (Colvin et al., 1996) .
The mammalian zinc-finger transcription factor Gfi1 is critical for hematopoiesis and the development of cochlear HCs and pulmonary neuroendocrine cells (reviewed by Jafar-Nejad and Bellen, 2004; Möröy, 2005; Kazanjian et al., 2006) . Gfi1 is orthologous to Drosophila Senseless that is required for the development of the fly's peripheral nervous system (Nolo et al., 2000) . Cellular events regulated by Gfi1 and Senseless include proliferation, cell fate decisions, differentiation and apoptosis. They can function as DNA-binding transcriptional repressors (Grimes et al., 1996; Zweidler-McKay et al., 1996) . In the case of Gfi1, this negative regulation requires its N-terminal SNAG domain (Grimes et al., 1996; Fiolka et al., 2006) . In addition to target gene repression, Senseless has been shown to function as a co-activator of bHLH proneural genes (Acar et al., 2006) . In the mouse inner ear, Gfi1 is expressed in developing cochlear and vestibular HCs from the onset of morphological differentiation onward (Wallis et al., 2003) . Gfi1 inactivation by homologous recombination leads to a dramatic cochlear phenotype, manifested by HC loss. Cochlear HCs show initial signs of morphological differentiation, but thereafter they rapidly degenerate, so that a large part them are lost already at birth. Outer hair cells (OHCs) rather than inner hair cells (IHCs) are the primary targets of Gfi1 deficiency. Interestingly, vestibular HCs are largely unaffected by Gfi1 loss, although also a part of these mutant cells show signs of degeneration at adulthood (Wallis et al., 2003; Hertzano et al., 2004) .
The homeodomain gene Prox1 is the vertebrate ortholog of the Drosophila Prospero, which was originally shown to be critical for the development of neuronal lineage of the fly (Doe et al., 1991; Manning and Doe, 1999; Li and Vaessin, 2000) . These studies and those performed with mice (Wigle and Oliver, 1999; Wigle et al., 1999 Wigle et al., , 2002 Sosa-Pineda et al., 2000; Hong et al., 2002; Petrova et al., 2002; Dyer et al., 2003) have demonstrated the role of Prospero/Prox1 as a link between terminal mitoses and the onset of differentiation, and in cell fate decisions of diverse cell types. Prospero/Prox1 can act as transcriptional repressors or activators, depending on the target gene and cellular context (Hong et al., 2002; Petrova et al., 2002; Choksi et al., 2006 ).
An earlier study showed that Prox1 is expressed in the developing inner ear sensory epithelia of the mouse (Bermingham-McDonogh et al., 2006) . Prox1 expression was shown in precursor cells and, after the onset of differentiation, in two types of cochlear supporting cells, the pillar and Deiters cells. In the present study, using a gain-of-function approach in explants cultures, we present evidence of novel target genes of Prox1 and show its impact on the HC phenotype and development. Gfi1 is one of the identified targets of repression by Prox1. We have used Prox1 overexpression to acutely deplete Gfi1 from HCs, and we provide mechanistic insights about the differentiation-and survival-promoting functions of Gfi1.
Materials and methods

Mice
The NMRI mouse strain was used for expression studies and explant cultures. Generation and the genotyping protocol of Gfi1: GFP knock-in mice (Yücel et al., 2004) and Fgfr3 knock-out mice (Colvin et al., 1996 ; obtained from Jackson Laboratory) have been described. For timed pregnancies, the morning of vaginal plug identification was taken as embryonic day 0.5 (E0.5) and the day of birth as postnatal day 0 (P0). Animal care was in accordance with institutional guidelines.
Explant cultures and viral infections
Organotypic explant cultures of the cochlear and utricular sensory epithelia were established at E15 and P1. Explants were maintained on pieces of Nuclepore filter membrane (Whatman) in F12 medium containing 10% fetal bovine serum (Hyclone) and penicillin. The adenoviral constructs AdGFP and AdProx1 were used. The transgenes were expressed under CMV promoter. Cloning and propagation of replication-deficient adenoviruses of serotype 2 have been described previously (Laitinen et al., 1998) . Prior to infection, dissected explants were stabilized on filters for 4 to 12 h. Infections were done in serumfree medium at the titers of 3.1 × 10 6 -10 7 pfu/ml for AdGFP and 3.3 × 10 6 -10 7 pfu/ml for AdProx1. Utricular explants were infected for 6 h, one explant in a volume of 20 μl, and thereafter maintained in serum-containing medium for 1 to 16 days. Cochlear explants were infected for 2 to 3 days and thereafter cultured in serum-containing medium for the same time period. Explants were fixed in 4% paraformaldehyde (PFA) in PBS for 15 min. Double and triple immunofluorescent staining in PBS containing 0.25% Triton-X-100 and 10% normal serum was performed using the following antibodies: goat polyclonal Prox1 (R & D), guinea pig polyclonal Gfi1 (Wallis et al., 2003) , rabbit polyclonal Atoh1 (Helms and Johnson, 1998) , rabbit polyclonal myosin VIIa (Hasson et al., 1997) Images were acquired through a CCD camera (DP70, Olympus) on a microscope (BX61, Olympus) and analySIS software (Olympus), and processed using Adobe Photoshop 7.0 (Adobe Systems). For quantification of adenoviral transduction efficiency in AdGFPinfected explants, numbers of cells with GFP fluorescence were counted in the population of myosin VIIa+HCs. For quantification of Gfi1 repression in AdProx1-and AdGFP-infected explants, numbers of Gfi1+cells were counted in the population of Prox1+/myosin VIIa+and GFP+/myosin VIIa+HCs, respectively. Corresponding quantification was done to determine the extent of Atoh1 repression in cochlear explants. At least 3 random microscopic fields were analyzed per explant.
Immunohistochemistry and detection of apoptosis
Whole heads from E13.5, E14.5, E15.0, E15.5 and E16.5 embryos and dissected inner ears from E17.5 and E18.5 embryos as well as P0 and P1 pups were fixed overnight in 4% PFA, embedded in paraffin and cut to 5-μm-thick sections. Inner ears from P7 and P25 mice were perilymphatically perfused with PFA prior to immersion in the fixative and thereafter decalcified in 0.5 M EDTA, pH 8.0. Epitopes were unmasked by microwave heating in 10 mM citrate buffer, pH 6.0, for 10 min. Antibodies used were the same as in wholemount stainings plus the rabbit polyclonal GFP antibody (Invitrogen). Detection was done with the Vectastain Elite Kits and DAB Detection Kit (Vector Laboratories). At least 5 serially sectioned inner ears were analyzed per age. To detect apoptotic cells, AdProx1-and AdGFP-infected cochlear explants, in which Prox1/GFP and myosin VIIa were first detected as wholemounts (see above), were embedded in paraffin and sectioned. ApopTag Peroxidase In Situ Apoptosis Detection Kit (Millipore), containing the sheep polyclonal digoxigenin antibody, was used according to manufacturer's instructions. Sections were counterstained with methyl green.
In situ hybridization
In situ hybridization was performed with 35 S-labelled riboprobes on PFA-fixed and paraffin-embedded sections as described (Wilkinson and Green, 1991) . At E16.5 and P0, inner ears from wildtype and Gfi1 GFP/GFP mice were analyzed for p57 Kip2 and p21 Cip1 expression. At both stages, six ears of each genotype were studied. In part of the views (Fig. 6A and Figs. 8F-I, L, M), autoradiographic silver grains in the dark field image were selected, coloured red and superimposed onto the brightfield image. AdProx1-and AdGFP-infected cochlear explants, six of each, and inner ears of E15.5 and P0 mice were prepared for paraffin sections and exposed to in situ hybridization with the Fgfr3 riboprobe. Hematoxylin was used for counterstaining.
Luciferase reporter assay
NIH 3T3 cells were plated at 5 × 10 5 cells in 12-well plates. After 18 h, cells were transfected using FuGENE HD (Roche). The amount of DNA was kept constant in each transfection by adjusting the amount of the empty expression plasmids (pAMC and FLAG). Cells were lysed 30 h after transfection and luciferase activity was measured with the Luciferase Dual Reporter Assay System (Promega). Firefly luciferace activity was normalized to Renilla luciferase levels using the pRL-TK plasmid (Promega) as an internal control reporter. The plasmids used have been characterized before: Gfi1 promoterdriven luciferase plasmid and Gfi1 expression plasmid (Yücel et al., 2004) and MycProx1/pAMC expression plasmid (Petrova et al., 2002) .
Results
Prox1 expression in the cochlea
To relate Prox1 expression to the stage of HC development, we first compared its expression with the proneural gene Atoh1, an early HC marker that drives precursors towards the HC phenotype, and with Gfi1 and myosin VIIa, both of which mark differentiated HCs (Figs. 1A-I ). In the presumptive organ of Corti, we did not detect Prox1 protein or mRNA at E14.5 or earlier stages (data not shown). Prox1 was first detected in the basal coil of the cochlea at E15.0 (Fig. 1A) . In this area, Prox1 was strongly expressed in the future OHCs, Deiters cells and pillar cells (Fig. 1A) , consistent with an earlier description (Bermingham-McDonogh et al., 2006) . In addition, not described in the earlier paper, we found weak expression in other types of non-sensory cells located on both sides of pillar and Deiters cells (Fig. 1A) . At E15.0, cells positive for Prox1 lacked signs of morphological differentiation, but, based on Atoh1 expression, a part of them had adopted the HC fate (Fig. 1C) . At this stage, the absence of Gfi1 in the area of future OHCs pointed to undifferentiated status of these cells (Fig. 1B) . This is in contrast to adjacent IHCs that did not express Prox1 at any stage, but that expressed Gfi1 from E14.5 onward (Fig. 1B) .
At E15.5, the first Gfi1-positive OHCs appeared in the basal coil of the cochlea, close to the lumen (Fig. 1E) . At the same stage, OHCs showed a decrease in Prox1 level (Fig. 1D ). At E15.5, myosin VIIa was not yet expressed in OHCs (Fig. 1F ), these observations being consistent with the data that Gfi1 is one of the earliest markers of HCs undergoing morphological differentiation (Wallis et al., 2003) . In contrast to OHCs, strong Prox1 expression was maintained in Deiters and pillar cells at E15.5 (Fig. 1D ). In addition, weak Prox1 expression persisted in other types of supporting cells, including inner phalangeal cells located underneath IHCs as well as Hensen and Claudius cells on the lateral side of the organ of Corti (Fig. 1D ). Prox1 induction followed a base-to-apex gradient along the length of the cochlear duct. At P0, Deiters and pillar cells showed strong Prox1 expression ( Fig. 1G ; Bermingham-McDonogh et al., 2006) whereas Gfi1 (Fig. 1H ), Atoh1 ( Fig. 1I ) and myosin VIIa (data not shown) were confined to HCs. In contrast to Bermingham-McDonogh et al. (2006) who showed rapid Prox1 downregulation in OHCs, we found more progressive downregulation. Prox1 was expressed in OHCs of the basal coil still at P0 (Fig. 1G ) and P1, but not anymore at P7 (Fig. 1J) . The weak Prox1 expression found at E15 in non-sensory cells on both sides of pillar and Deiters cells (Figs. 1A, D) was downregulated by P0, except in Hensen and Claudius cells (Fig. 1G) . Interestingly, in the postnatal cochlea, at P7 and P25, Prox1 was still present in Deiters and pillar cells, most strongly in the outer pillar cells and lateralmost Deiters cells (Figs. 1J, K).
Taken together, the largely non-overlapping expression pattern of Prox1 and Gfi1 in the developing organ of Corti suggested for a possible inhibitory relationship, in either direction. The fact that Prox1 expression was unaltered in the inner ear sensory epithelia of homozygous Gfi1 GFP/GFP mutant mice (Yücel et al., 2004) , as analyzed at E15.5 ( Fig. 1L ) and P0 ( Fig. 1M ) suggested that Prox1 is an upstream regulator in this putative relationship. As opposed to Prox1, the recently identified member of the family of Prospero-related homeobox genes, Prox2 (Nishijima and Ohtoshi, 2006) was not expressed in the inner ear sensory epithelia at any stage, as analyzed by in situ hybridization (Figs.1N , O). The embryonic nodose ganglion was used as a positive control for Prox2 expression ( Fig. 1P ; Nishijima and Ohtoshi, 2006) .
Prox1 expression in the utricle
We next compared the expression of Prox1 with Atoh1 and Gfi1 in the sensory epithelium of utricle, one of the vestibular organs (Figs. 2A-I). As compared to the organ of Corti of the cochlea where progenitors terminally mitose between E12 and E14, cells exit the cell cycle and start to differentiate a few days earlier in the vestibular sensory epithelia (Ruben, 1967) . Prox1 was present in the utricle at E13.5, at the earliest stage analyzed ( Fig. 2A) . The expression was maintained at E15.0 (Fig. 2B ) and P1 ( Fig. 2C for P0 ), these data differing from an earlier study (Bermingham-McDonogh et al., 2006) in which Prox1 was not detected in the utricle after E16.5. Between E13.5 and P1, Prox1 was present in supporting cells, while HCs, identified by their morphology and location close to the lumen, lacked expression (Figs. 2A-C). Staining of adjacent sections with antibodies against Gfi1 and Atoh1 confirmed that the HC region lacked Prox1 (Figs. 2D-I). Of note, after the onset of differentiation, utricular HCs showed rapid Atoh1 downregulation, so that already at E15 a large part of them were only weakly positive or completely lacked Atoh1. The decrease in Atoh1 expression progressed further along development ( Fig. 2I ). This is different from Gfi1 that was present in HCs throughout development (Figs. 2D-F). Together, the presence of Prox1 in utricular supporting cells and its largely complementary expression pattern relative to the HC markers suggest for a role, similar as in the organ of Corti, as a positive regulator of supporting cell development and/or as a repressor of the HC phenotype.
Adenoviruses infect hair cells in explant cultures
To be able to overexpress Prox1 in HCs in explant cultures, we examined the potential of adenoviral transduction into these cells. Adenoviruses of serotype 5 with the GFP or Prox1 transgene under CMV promoter (Laitinen et al., 1998) were used. In utricular explants, a 6-hour-long infection resulted in efficient transduction into HCs (Fig. 3 ). Transgenes were expressed in myosin VIIa+utricular HCs already after 1 day in vitro (DIV) (data not shown). Expression became more prominent after 3 DIV (Figs. 3A-D‴) and was maintained throughout the culture period, up to 16 days (Figs. 3E-F‴; data not shown). Quantification in utricular explants infected with AdGFP at E15 and P1, and maintained for 3 DIV showed that 64% and 39%, respectively, of HCs were double-labeled for myosin VIIa and GFP (a total of 958 HCs in six E15 explants and 989 HCs in five P1 explants counted).
For successful adenoviral transduction into cochlear HCs, an infection time longer than in the case of utricular HCs was needed (see Materials and Methods; Figs. 4 and 7) . In P1 cochlear cultures, 83% of OHCs were infected by AdGFP after 4 DIV (totally 465 OHCs in 3 explants counted). Transduction into IHCs was variable between explants. Similarly, as compared to OHCs, supporting cells of the inner ear sensory epithelia were more inefficiently and variably transduced by adenoviruses. Together with the fact that no adverse effects on the morphology and survival of HCs were seen, our data speak for the usefulness of adenoviruses in gene transfer into both utricular and cochlear HCs in vitro. 
Ectopic Prox1 expression represses Gfi1 in utricular hair cells
Utricular explants were infected with AdProx1 at E15 and P1, and cultured for 3 and 10 days. We first focused on myosin VIIa and found that its expression was unaltered in AdProx1-infected HCs (Fig. 3) . To study the effect of ectopic Prox1 expression on Gfi1, which is normally expressed throughout the HC population (Figs. 2E-G), AdProx1-infected explants were triple-labeled with antibodies against Prox1, Gfi1 and myosin VIIa. Hair cells with ectopic Prox1 showed strong repression of Gfi1, as opposed to AdGFPinfected HCs (Figs. 3A-F‴) . Quantification revealed that in explants infected with AdProx1 at E15 and maintained for 3 DIV, only 18% of Prox1+/myosin VIIa+HCs showed Gfi1 expression. In AdGFP-infected explants, this value was 96% for GFP+/myosin VIIa+HCs (Fig. 5A ). Gfi1 repression was significant also in cultures set up at P1, although the effect was somewhat weaker than in E15 explants (Fig. 5A) . Together, these results show that Gfi1 is a target of repression by Prox1.
Prox1 overexpression represses Gfi1 and Atoh1 in cochlear hair cells
In AdProx1-infected cochlear explants, endogenous Prox1 was expressed in supporting cells located underneath the lumenal HC expression of the Prox1 transgene in HCs was clearly stronger than its endogenous expression (Fig. 4) . In cochlear cultures initiated at E15 and P1, and maintained for 5 and 4 DIV, respectively, AdProx1-infected HCs showed efficient repression of Gfi1, while myosin VIIa expression was unaffected (Figs. 4A-D″) . Gfi1 was repressed both in OHCs and IHCs, but the effect was more pronounced in OHCs (Figs. 4A-D″) . Quantification in cochlear cultures initiated at P1 revealed that only 2% of Prox1+/myosin VIIa+OHCs were immunoreactive for Gfi1, while this value was 100% for GFP+/myosin VIIa+OHCs in AdGFP-infected cultures (Fig. 5A) .
Atoh1 has been suggested to positively regulate Gfi1 expression in the inner ear HCs and the intestinal epithelium (Wallis et al., 2003; Shroyer et al., 2005) . Therefore, the observed Gfi1 repression following AdProx1 transduction might be an indirect effect, a consequence of interaction between Prox1 and Atoh1. This could not be studied in utricular HCs, because these cells showed rapid downregulation of Atoh1 during embryogenesis, in contrast to cochlear HCs where Atoh1 expression was maintained until neonatal stages (Figs. 1 and 2 ). AdProx1-infected cochlear explants dissected at E15 and maintained for 5 DIV showed strong Atoh1 repression in HCs, in contrast to HCs in AdGFP-infected explants (Figs. 4E-F″) . Quantification showed that only 2% of Prox1+OHCs were immunoreactive for Atoh1, while this value was 100% for GFP+OHCs in AdGFP-infected cultures (Fig. 5B) . Thus, Prox1 overexpression leads to Atoh1 repression that is similar magnitude to Gfi1 repression (Fig. 5A ).
Prox1 regulates Gfi1 promoter activity
We next studied whether Prox1 can regulate transcription of Gfi1 independently of Atoh1. Luciferase assays were done with NIH 3T3 cells. As assessed after 36 h in vitro and using Atoh1 transfected 3T3 cells as positive controls, Atoh1 was not expressed in these cells (data not shown). We used a previously characterized, 600-bp-long Gfi1 promoter fragment that was appended to luciferase reporter cDNA (Yücel et al., 2004 ). An autoregulatory mechanism has earlier been shown at the Gfi1 locus, as evidenced by strong repression of Gfi1 reporter activity by co-transfection with the Gfi1 expression plasmid (Yücel et al., 2004) . This was also seen in our assays (Fig. 5C) . The results showed that Prox1 expression plasmid represses transcriptional activity of Gfi1 promoter in a dose-dependent manner (Fig. 5C ), implying that Prox1 and Gfi1 can interact, at least in part, independently of Atoh1.
Prox1 overexpression does not activate Fgfr3 and Id1 in hair cells
Ectopic Prox1 expression activates Fgfr3 transcription in blood vascular endothelial cells (BECs) (Shin et al., 2006) . In agreement with earlier data (Peters et al., 1993; Pirvola et al., 1995; BerminghamMcDonogh et al., 2001) , Fgfr3 was strongly expressed in cochlear OHCs and underlying supporting cells at E15.5, at the onset of morphological differentiation (Fig. 6A) . During later stages of development, strong Fgfr3 expression was maintained in supporting cells, while it was downregulated in OHCs (data not shown; Pirvola et al., 1995; Bermingham-McDonogh et al., 2001 ). This spatiotemporal expression pattern corresponds to Prox1 expression (compare Fig. 6A and Fig. 1D) , suggesting for a possible interaction between these factors. We first analyzed Prox1 expression in the organ of Corti of Fgfr3 knock-out mice at E15.5 and P0. It was comparable to the expression seen in wildtype animals (compare Fig. 6B and Fig. 1D ). To study whether Prox1 overexpression can activate Fgfr3 in OHCs, AdProx1-and AdGFP-infected cochlear explants (P1) were cultured for 4 days, and thereafter paraffin sections were prepared and exposed to in situ hybridization with the Fgfr3 probe. Adjacent sections were immunostained with Prox1 or GFP antibodies to reveal infected areas of cochlear explants. In these areas, HCs did not show Fgfr3 upregulation (Figs. 6C-F) . Together, these data argue against a close . NIH 3T3 cells were co-transfected with the Gfi1-luciferase reporter (1 μg) along with the Prox1 (5, 20, 100 ng) expression plasmid or the corresponding empty pAMC plasmid. For comparison, negative autoregulation by Gfi1 is shown, using the Gfi1-luciferase reporter (500 ng) along with the Gfi1 (5, 20 ng) expression plasmid or the empty FLAG plasmid. The relative luciferase activity is the firefly luciferase activity normalized to that of renilla luciferase. This activity (mean±s.d) is presented as percentage of empty control from 4 independent experiments, each in triplicate.
relationship between Prox1 and Fgfr3 in cochlear HCs, in either direction.
Ectopic Prox1 expression activates Id2 in differentiated BECs (Petrova et al., 2002) . Transcripts of several members of the Id family have been localized to cochlear supporting cells and Ids have been suggested to antagonize Atoh1 expression (Jones et al., 2006) . These data prompted us to determine whether Prox1 overexpression can activate Ids in HCs. Of the four members of the Id family, we focused on Id1, which negatively regulates transcription of bHLH genes in cells such as neuronal precursors (Lyden et al., 1999; Jögi et al., 2002) . Consistent with earlier data at the mRNA level (Jones et al., 2006) , sections through the inner ear at E15.0 and P0 showed the presence of Id1 protein in cochlear supporting cells (data not shown). In addition, at these stages, we localized Id1 to vestibular supporting cells (Figs.  6G, H) . Utricular explants were infected with AdProx1 at E15 and maintained for 10 DIV. Triple-labeling with antibodies against Prox1, Id1 and the hair-cell-marker parvalbumin failed to show Id1 expression in infected utricular HCs (Figs. 6I, I′) . Thus, ectopic Prox1 expression does not upregulate Id1 in this cellular context.
Functional consequences of Prox1 overexpression
We next determined whether Prox1 overexpression has functional consequences on the differentiated HC phenotype. AdProx1 infection did not affect HC survival in utricular explants, even after long-term culture period, up to 16 DIV ( Fig. 3; data not shown) . In contrast, in cochlear cultures initiated at E15, at the onset of HC differentiation, and maintained for 5 DIV, dProx1 transduction resulted in OHC degeneration (Figs. 7A-H″) . This degeneration had a distinct spatial pattern along the length of the cochlear duct, so that the basal part showed extensive OHC loss, while most of OHCs were still present in the apical part, albeit often showing signs of degeneration (Figs. 7A-D″) . This degeneration pattern parallels the base-to-apex differentiation gradient. As shown in sections cut through AdProx1-infected cochlear explants, the presence of DNA fragmentation indicated that OHCs were lost through apoptosis (Figs. 7E, F) . Interestingly, in the same explants, most of IHCs were intact despite AdProx1 infection (Figs. 7B-C″, H-H″). Explants transduced with AdGFP did not show HC degeneration (Figs. 7G-G″) . Notably, in contrast to cochlear cultures set up at E15, those started at P1 and cultured for 4 days showed only low numbers of lost OHCs (Figs. 4C-D″) . These results demonstrate that OHC apoptosis following Prox1 overexpression is tightly linked to developmental stage.
Gfi1 regulates p57
Kip2 expression in cochlear outer hair cells
We interpret that the specific degeneration of OHCs following AdProx1 transduction is linked with Gfi1 repression, based on the phenotype of Gfi1 knock-out mice (Wallis et al., 2003) . In these mutants, OHCs degenerate rapidly after they have started to differentiate, while IHCs degenerate not before later postnatal stages. Even more strikingly, adult vestibular HCs are largely intact in these mutant animals (Wallis et al., 2003) . These data prompted us to search for mechanisms underlying the opposite responses of different types of inner ear HCs to Gfi1 deficiency. In line with our earlier data (Laine et al., 2007) , the cyclin-dependent kinase inhibitor (CKI) p57 Kip2 was expressed in OHCs, as demonstrated in cochlear wholemounts by p57 Kip2 staining at E17.5 (Fig. 8A ) and by double-staining for p57 Kip2 and myosin VIIa at P0 (Figs. 8B, B′) . p57 Kip2 expression was initiated between E15.5 and E16.5, and it followed a base-to apex gradient along the length of the cochlear duct (data not shown). In contrast to OHCs, only a small number of IHCs showed the presence of p57 Kip2 and this expression was very weak (Figs. 8A, B) . Available data on other cell types show that, in addition to a role as a negative cell cycle regulator, p57
Kip2 can control differentiation, maturation and apoptosis (Yan et al., 1997; Zhang et al., 1997; Dyer and Cepko, 2000; Joseph et al., 2003) . Based on this knowledge and on the results on p57 Kip2 expression in the cochlea (Figs. 8A, B ; Laine et al., 2007) , we next studied whether the death-prone phenotype of Gfi1-deficient cochlear OHCs is associated with altered p57 Kip2 expression.
We found that p57 Kip2 expression was downregulated in HCs of AdProx1-infected cochlear explants as compared to control specimens (data not shown). To be able to more deeply penetrate into the interaction between Gfi1 and p57
Kip2
, we analyzed Gfi1 GFP/GFP knock-in mice in which the coding region of Gfi1 is replaced by GFP cDNA (Yücel et al., 2004) . We first confirmed that these homozygotes show a similar inner ear phenotype as earlier reported for the Gfi1 knock-out mice (Wallis et al., 2003; Hertzano et al., 2004) . We found that HC degeneration progressed in a base-to-apex gradient through the cochlear duct. The rapid progression of OHC death was striking. As shown by GFP fluorescence, OHCs were present in Gfi1 GFP/GFP mutant mice at E17.5, but they showed abnormal morphology and were not arranged as three distinct rows (Figs. 8C, D) . Most of OHCs were severely pathological or were lost at P0 (Fig. 8E) . We studied the possibility that Gfi1-deficient OHCs re-enter the cell cycle prior to their death. We did not find evidence for this possibility, based on the lack of staining with the antibody against Ki-67, a proliferation marker, in the organ of Corti of the mutant mice between E17.5 and P1 (data not shown). Analysis of cochlear wholemounts at E16.5, E17.5 and P0 revealed that, in contrast to wildtype mice, p57
Kip2 expression was absent in
OHCs from Gfi1 GFP/GFP mutant mice (Figs. 8DV , EV ) . This was also seen at the mRNA level in sections through inner ears from E16.5 and P0 (Figs. 8F, G) animals that were exposed to in situ hybridization. Of note, at P0, the lack of p57 Kip2 was evident in OHCs throughout the cochlear duct, including its upper part where OHCs appeared still normal (Fig.  8G) . In contrast to p57
, expression of p21
Cip1
, another member of the Cip/Kip family of CKIs that has been shown to be expressed in the inner ear HCs (Mantela et al., 2005) , was unaltered in the mutants (Figs. 8H, I ). As earlier described (Nagahama et al., 2001; Westbury et al., 2001) , p57
Kip2 was strongly expressed in the inner sulcus, a nonsensory region of the cochlea (Fig. 8F ). This expression was maintained in Gfi1 GFP/GFP mutant animals (Fig. 8G) , consistent with the fact that Gfi1 is not expressed in this region (data not shown). In contrast to cochlear OHCs, most of utricular HCs were devoid of p57
Kip2 protein and mRNA, as seen during late-embryogenesis and around birth in paraffin sections exposed to immunostaining or radioactive in situ hybridization (Figs. 8J-M) . Interestingly, a small number of utricular HCs showed the presence of p57 Kip2 (Figs. 8J, L) and this expression was maintained in the Gfi1 GFP/GFP mutant animals (Figs. 8K, M) . Together, these data suggest that Gfi1/p57 Kip2 interaction does not have a pivotal role in the regulation of survival of vestibular HCs, in contrast to cochlear OHCs.
Discussion
In the current study, we have used adenoviral-mediated overexpression approach in organotypic cultures of the inner ear sensory epithelia to study gene interactions that regulate the development of HCs and supporting cells. These cell types are derived from common precursors and they do not show phenotypic conversion in mammals.
We report the identification of Prox1 as a repressor of Atoh1 and Gfi1, two transcription factors critical for HC differentiation, and suggest that Prox1 antagonizes the differentiated HC phenotype. This antagonism is likely to have physiological relevance in supporting cells where endogenous Prox1 is expressed (present study; Bermingham-McDonogh et al., 2006) . We show that in response to Prox1 overexpression, a specific HC population, the cochlear OHCs, degenerate due the dependence of these cells on Gfi1 for survival. Further, we present evidence of a novel interaction between Gfi1 and p57 Kip2 ,
suggesting that this cell cycle regulator mediates the differentiationand survival-promoting functions of Gfi1. These data provide key insights about transcriptional regulation of cellular differentiation within the inner ear sensory epithelia.
Prox1 target genes in the inner ear sensory epithelia
The rapid and strong downregulation of both Atoh1 and Gfi1 in the inner ear HCs with Prox1 overexpression suggests for a close relationship between these factors. Because Atoh1 positively regulates Gfi1 (Wallis et al., 2003; Shroyer et al., 2005 ), Prox1's repressive action on Gfi1 is likely to be partially indirect. This is supported by the results that Gfi1 repression was more extensive amongst AdProx1-infected cochlear HC as compared to AdProx1-infected utricular HCs. Normally, all cochlear HCs express both Gfi1 and Atoh1 whereas all utricular HCs show the presence of Gfi1, but only a part of them express Atoh1. However, results from our luciferase assays using NIH 3T3 fibroblasts suggest that Prox1 can repress transcriptional activity of Gfi1 reporter. Thus, Prox1 and Gfi1 can interact, in part, independently of Atoh1.
Concerning Atoh1 repression, a possibility was that this effect is due to Prox1 overexpression-induced activation of Ids, the negative regulators of bHLH genes. This possibility was relevant, since Prox1 has been shown to activate Ids in another cellular context (Petrova et al., 2002) . However, our results in the inner ear HCs argue against regulation of Id1 expression by Prox1 and, thus, point to a more direct interaction between Prox1 and Atoh1 in this context.
It has been recently shown that Senseless and Prospero, the Drosophila orthologs of Gfi1 and Prox1, interact in the fly eye. It was shown that Prospero is a target, most likely indirect one, of repression by Senseless (Xie et al., 2007) . However, our results show unaltered Prox1 expression in the inner ear sensory epithelia of Gfi1 GFP/GFP mutant mice. Particularly, Prox1 was not upregulated in their cochlear or vestibular HCs. Thus, present results suggest that, in the inner ear sensory epithelia of the mouse, this interaction is primarily through Prox1′s repressive action on Gfi1.
Prox1 regulates cellular differentiation in the inner ear sensory epithelia
In the organ of Corti of the cochlea where cellular development is better uncovered relative to the vestibular sensory epithelia (reviewed by Kelley, 2006) , Prox1 expression was initiated in precursor cells shortly before they showed signs of morphological differentiation as OHCs or supporting cells. Thereafter, Prox1 expression gradually disappeared from OHCs, but was maintained in supporting cells during maturation. Based on the late timing of Prox1 induction (present study; Bermingham-McDonogh et al., 2006) relative to cell cycle exit (Ruben, 1967; Chen and Segil, 1999; Lee et al., 2006) and on the fact that these events have opposite gradients along the length of the cochlear duct, Prox1 appears not to regulate terminal mitoses of precursors, a role that has been suggested for Prospero in the Drosophila nervous system (Li and Vaessin, 2000) . The late timing of Prox1 induction also argues against a role in the cell type specification and commitment processes in the prosensory epithelia. The base-to-apex gradient of the onset of Prox1 expression parallels the well-known differentiation gradient. Thus, these correlative data suggest for a role of Prox1 during cellular differentiation in the inner ear sensory epithelia. The primary site of action of Prox1 appears to be supporting cells, both of the cochlea and vestibular organs, based on the widespread Prox1 expression in this cell population. These data together with the current results that Atoh1 and Gfi1 are repressed in HCs with Prox1 overexpression suggest that this transcription factor antagonizes the differentiated HC phenotype in inner ear supporting cells.
In addition to serving as transcriptional repressors, Prox1 (Hong et al., 2002; Petrova et al., 2002) and Prospero (Choksi et al., 2006) can activate target genes. Thus, Prox1 may activate transcription of genes that promote differentiation of inner ear supporting cells, in addition to its role in antagonizing the HC phenotype. As demonstrated in endothelial cells, Prox1 can activate Fgfr3 (Shin et al., 2006) . Interestingly, Prox1 and Fgfr3 are expressed in cochlear supporting cells, and Fgf-Fgfr3 signaling has been suggested to promote development of these cells (present data; Peters et al., 1993; Pirvola et al., 1995; Colvin et al., 1996; Bermingham-McDonogh et al., 2001 Mueller et al., 2002) . However, Fgfr3 was not activated in cochlear HCs that overexpressed Prox1, demonstrating that ectopic Prox1 is insufficient to reprogram cochlear HCs towards a supporting cell phenotype that is characterized by high-level expression of Fgfr3, a known Prox1 target gene.
Acute Gfi1 repression leads to outer hair cell degeneration
Ectopic Prox1 expression led to cochlear OHC degeneration. We interpret that the immediate cause of this degeneration is Gfi1 repression, based on the corresponding phenotype of AdProx1-infected cochlear explants and cochleas of Gfi1 null mutant mice (Wallis et al., 2003) . The acute Gfi1 repression performed in the present study gives mechanistic insights into Gfi1′s function. The results show that Gfi1 repression is devastating for OHCs during the late-embryonic differentiation period, while OHCs undergoing maturation after birth are more resistant to Gfi1 depletion. Also the distinct spatial pattern of OHC degeneration in AdProx1-infected cochlear explants during lateembryogenesis, the more differentiated OHCs in the basal part being lost at the stage when less differentiated OHCs in the upper part were still present but showed signs of degeneration, suggests that Gfi1 is critical for the differentiation and survival of these cells during a limited time frame of the developmental program.
In the organ of Corti, Prox1 was strongly expressed in two types of supporting cells, the Deiters and pillar cells. Interestingly, Prox1 was also weakly expressed in OHCs during late-embryogenesis (Fig. 1) . This expression disappeared after birth. Taking into account that Prox1 overexpression resulted in Gfi1 repression and OHC degeneration, the weak Prox1 expression in normal, Gfi1-expressing OHCs is interesting. The data suggest that high Prox1 levels, as seen in Deiters and pillar cells, are required for efficient repression of factors that promote the HC phenotype. This can also be concluded from our luciferase assays, showing that Prox1 represses transcriptional activity of the Gfi1 promoter in a dose-dependent fashion. These considerations raise the question of the role of endogenous Prox1 in lateembryonic OHCs. In contrast to OHCs, IHCs did not show Prox1 expression at any stage (present data; Bermingham-McDonogh et al., 2006) . IHCs differentiate before OHCs, as evidenced by earlier induction of Atoh1, Gfi1 and myosin VIIa in these cells (Fig. 1) . Thus, Prox1 appears to act as a brake of OHC differentiation relative to the timing of differentiation of IHCs. This difference between the two types of cochlear HCs in temporal development may be important for the generation of proper cytoarchitecture of the organ of Corti and for processes such as the establishment of neuronal innervation into HCs.
Gfi1/p57
Kip2 interaction in hair cells A striking consequence of AdProx1 infection and the ensuing Gfi1 repression was cochlear OHC degeneration, while most of cochlear IHCs and utricular HCs were unaffected. These results are consistent with the phenotype of Gfi1 null mutant mice (Wallis et al., 2003) . What might be the mechanisms by which Gfi1 promotes OHC survival and that do not to operate in other types of inner ear HCs? We found that p57
Kip2 expression, which is normally seen in developing OHCs, was abolished from OHCs of Gfi1 GFP/GFP mutant mice. These results suggest that Gfi1 positively regulates of p57 Kip2 expression in OHCs.
This interaction appears not to be present in vestibular HCs, based on the lack of p57 Kip2 in most of utricular HCs of both normal and mutant animals. However, a small number of utricular HCs showed p57 Kip2 expression, but it was unaltered in Gfi1 GFP/GFP mutant mice. These data speak for a very specific dependence of Gfi1/p57 Kip2 interaction on cellular context and suggest for the involvement of additional factors in this interaction. In this respect, it is interesting that OHCs from Gfi1 GFP/GFP mutant mice showed unaltered expression of p21
Cip1
, another CKI that is present in HCs and that has been shown to be regulated by Gfi1 in other cell types (Karsunky et al., 2002; Duan and Horwitz, 2003; Hock et al., 2004; Zeng et al., 2004; Duan et al., 2005) . Based on the general view that mammalian Gfi1 represses target gene transcription (Grimes et al., 1996; Zweidler-McKay et al., 1996) , its role in cochlear OHCs as an activator of p57 Kip2 appears to be indirect.
However, a few studies have proposed that Gfi1 and its close homolog Gfi1b can function as direct transcriptional activators (Sharina et al., 2000; Osawa et al., 2002) , and, thus, a possibility of a direct interaction between Gfi1 and p57 Kip2 in OHCs cannot be excluded.
As a CKI, p57 Kip2 can associate with and inhibit catalytic activity of cyclin-cyclin dependent kinase complexes, and thereby regulate cell cycle exit and the maintenance of the postmitotic state (reviewed by Cunningham and Rousssel, 2001 ). In the cochlea, the late timing of p57 Kip2 induction, concomitantly with the onset of Gfi1 expression, makes it unlikely that this CKI regulates cell cycle exit of progenitors. p57 Kip2 may control the maintenance of the postmitotic state of differentiated HCs, but this role is likely to be a collaborative one together with other CKIs present in HCs (present data; Chen et al., 2003; Mantela et al., 2005; Laine et al., 2007) . Consistent with this suggestion, Gfi1-deficient cochlear OHCs, lacking p57 Kip2 in contrast to their normal counterparts, failed to show cell cycle reactivation prior to their death. Importantly, in addition to a role as a cell cycle regulator, other roles have been suggested for p57 Kip2 . It has been shown to control cellular differentiation, maturation and apoptosis, and these cell cycle-independent functions seem to depend on its non-CKI regions (Yan et al., 1997; Zhang et al., 1997; Dyer and Cepko, 2000; Joseph et al., 2003) . Our data suggest that Gfi1/p57 Kip2 interaction promotes differentiation and survival of cochlear OHCs, in contrast to other types of inner ear HCs. Thus, these results seem to explain, in part, the death-prone phenotype of cochlear OHCs versus death-resistance of utricular HCs following Prox1 overexpression.
In conclusion
Molecular discrimination of inner ear sensory epithelial cells underlies the development of therapeutic strategies to treat hearing and balance disorders. Our data on Atoh1 and Gfi1 repression and on cochlear OHC degeneration in response to Prox1 overexpression show that transcriptional reprogramming with functional consequences can be achieved in differentiated HCs. Atoh1 gene transfer into inner ear non-sensory cells has been shown to induce conversion of these cells to HCs, both in vitro (Zheng and Gao, 2000) and in vivo (Izumikawa et al., 2005) . However, despite myosin VIIa induction, many of the newly propagated cells retained morphological characteristics of supporting cells (Izumikawa et al., 2005) . Based on the data from the current study that Prox1 antagonizes the differentiated HC phenotype through repression of Atoh1 and Gfi1, a more complete phenotypic conversion might be achieved through Prox1 inhibition in conjunction with Atoh1 upregulation. In the current study, we have identified three novel gene interactions, showing that Prox1 is a repressor of Atoh1 and Gfi1, and that Gfi1 targets p57 Kip2 . In addition to the inner ear, these interactions are likely to have functional relevance in other developing tissues and in diseases.
